HEMS II: Cognition at Altitude in HEMS - Part II

Sponsor
Institute of Mountain Emergency Medicine (Other)
Overall Status
Recruiting
CT.gov ID
NCT05073406
Collaborator
University Grenoble Alps (Other), Università degli Studi di Trento (Other), Medical University Innsbruck (Other)
72
1
2
16
4.5

Study Details

Study Description

Brief Summary

The aim of the current study is to evaluate under blinded conditions, both in a simulated environment and during helicopter flight, the effect of a rapid (within 20 minutes) exposure to altitude (4000 m asl) on physiological parameters and selected cognitive domains, in providers operating in helicopter emergency medical service (HEMS) exposed to hypobaric hypoxia or to hypobaric normoxia (H0: cognitive effects under hypobaric hypoxia = cognitive effects under hypobaric normoxia). Simulated environment will allow to control different factors. The parallelism between a study branch conducted in a simulated environment and another one conducted under a real-life condition will allow to evaluate the additive effects on additional stressor factors (processive and systemic ones).

  • Simulation branch: each participant will take part in three research sessions: a familiarization session and two experimental sessions in simulation facility called terraXcube (test 1 and 2). On test 1 and test 2 each group will be exposed twice to the simulated altitude of 4000 m asl (under hypobaric hypoxia or hypobaric normoxia conditions) according to the randomization protocol. Participants will perform the neurocognitive tests three times on each of the two tests: before the ascent (TC0), after 5 min from the end of the ascent (TC1) and after around 30 min (TC2), to investigate European Union Aviation Safe Agency (EASA) proposed recommendations. After completing each neurocognitive test session, participants will be asked to rate their performance using a visual analogue scales (VAS). All participants will wear the vital parameters monitoring system during the entire duration of the tests inside the chamber, as well as the cerebral oxygen saturation (ScO2) sensor. Samples will be collected by saliva, urine and/or capillary blood. The same schedule is repeated in each test session.

  • In-field branch: each participant will take part in three research sessions: a familiarization session and two experimental sessions during helicopter flights (test 1 and 2). On test 1 and test 2 each group will be exposed twice to the altitude of 4000 m (under hypobaric hypoxia or hypobaric normoxia conditions) according to the randomization protocol. Participants will perform the neurocognitive test two times on each test: before the ascent (TC0), after around 5 min from the end of the ascent (TC1). After completing each neurocognitive tests, participants will be asked to rate their performance using a visual analogue scales (VAS). All participants will wear the vital parameters monitoring system during the entire duration of the tests. Samples will be collected. The same schedule is planned in each test session.

Condition or Disease Intervention/Treatment Phase
  • Other: Altitude exposure in hypobaric normoxic condition
  • Other: Altitude exposure in hypobaric hypoxic condition
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Interventional, non-pharmacological, randomized, controlled, double-blinded, cross-overInterventional, non-pharmacological, randomized, controlled, double-blinded, cross-over
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Cognitive Performance After Acute Exposure to Altitude - Part II
Actual Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Hypobaric normoxia

Altitude exposure in hypobaric normoxic condition

Other: Altitude exposure in hypobaric normoxic condition
Altitude exposure with oxygen supplementation to achieve normoxia at altitude

Sham Comparator: Hypobaric hypoxia

Altitude exposure in hypobaric hypoxic condition

Other: Altitude exposure in hypobaric hypoxic condition
Altitude exposure with air supplementation to obtain a sham comparator arm

Outcome Measures

Primary Outcome Measures

  1. Psychomotor Vigilance Test - PVT [Changes from baseline (T0) to altitude measurement (respectively after 5 min - T1 and after 30 min - T2)]

    Changes in reaction time using a computer-based test (PVT)

  2. Digit-Symbol Substitution Task - DSST [Changes from baseline (TC0) to altitude measurement (respectively after 5 min - TC1 and after 30 min - TC2)]

    Changing in processing speed using a computer based test (DSST)

  3. 2-back Test [Changes from baseline (TC0) to altitude measurement (respectively after 5 min - TC1 and after 30 min - TC2)]

    Changing in working memory using a computer based test (2-back test)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Members of emergency medical services (EMS) and search and rescue (SAR) services with an occupational licence, an age between 18 and 60 years, an American Society of Anaesthesiologists (ASA) physical status class I, providing informed and written consent with no current COVID 19 symptoms and temperature ≤ 37.5°on test days, not being tested positive for COVID-19, ideally COVID-19 vaccinated.

Exclusion Criteria:

Members under the age of 18 years, an ASA physical status class II or more, a medical history of psychiatric disorders and neurological diseases, previous high altitude pulmonary oedema (HAPE) or high altitude cerebral oedema (HACE) or severe acute mountain sickness (AMS) (defined as a Lake Louise Score (LLS) > 9) occurred at altitudes similar to the ones tested in the study, no informed consent, current COVID 19 symptoms, being tested positive for COVID-19 or symptoms and body temperature ≥ 37.5°on test days.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Eurac Research, Institute of Mountain Emergency Medicine Bolzano BZ Italy 39100

Sponsors and Collaborators

  • Institute of Mountain Emergency Medicine
  • University Grenoble Alps
  • Università degli Studi di Trento
  • Medical University Innsbruck

Investigators

  • Principal Investigator: Giacomo Strapazzon, MD PhD, Eurac Research, Institute of Mountain Emergency Medicine
  • Principal Investigator: Marika Falla, MD PhD, University of Trento, Center for Mind/Brain Sciences - CIMeC
  • Principal Investigator: Michiel van Veelen, MD, Eurac Research, Institute of Mountain Emergency Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Giacomo Strapazzon, MD PhD, Principal Investigator, Institute of Mountain Emergency Medicine
ClinicalTrials.gov Identifier:
NCT05073406
Other Study ID Numbers:
  • 98-2021
First Posted:
Oct 11, 2021
Last Update Posted:
Oct 11, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 11, 2021